BVI capacity constraints cost Botswana key market

Botswana’s Vaccine Institute Faces Market Challenge

The Botswana Vaccine Institute (BVI) is grappling with capacity limitations in producing foot-and-mouth disease (FMD) vaccines. This struggle is impacting its standing in the regional market.

South Africa Seeks New Suppliers

South Africa, historically a major client for BVI, has reportedly begun exploring alternative suppliers for FMD vaccines. This shift comes after years of reliance on the state-owned Botswanan producer.

Impact on Regional Supply

The BVI’s challenges in meeting increasing demand hint at broader implications for FMD vaccine availability in the region. Other nations may also need to diversify their vaccine sourcing if BVI’s production remains constrained.